HOMA-IR Reference Tool

Estimate your insulin sensitivity using the Homeostasis Model Assessment (HOMA-IR) formula from fasting glucose and fasting insulin. A wellness reference for general tracking only — not a diagnostic tool. Supports mg/dL and mmol/L glucose units.

Glucose unit

Fasting glucose

mg/dL

Fasting insulin

µIU/mL

This is a wellness reference, not a diagnostic tool. HOMA-IR is a research-derived estimate of insulin sensitivity from a single fasting blood draw. It is not used clinically to diagnose insulin resistance, prediabetes, or type 2 diabetes — those require glucose tolerance testing, HbA1c, and clinical evaluation. Always discuss results with a qualified healthcare provider.

HOMA-IR Score

Within typical
<1.0 Upper typical
1.0–1.9 Above typical
2.0–2.9 Significantly above
≥3.0

HOMA-IR is a wellness reference, not a diagnostic test. Reference ranges are population-specific — there is no single universal cutoff. Values in the above-typical ranges are commonly seen with reduced insulin sensitivity — discuss with your healthcare provider to interpret this result in context.

What HOMA-IR Tells You

HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) is a research-derived mathematical estimate of insulin sensitivity. The physiology it reflects: when cells in the liver, muscle, and fat tissue respond less efficiently to insulin, the pancreas tends to compensate by secreting more — so both glucose and insulin may remain in their reference ranges while subtle changes accumulate. HOMA-IR captures this dynamic by multiplying fasting glucose by fasting insulin, so the score rises even when neither value individually crosses a typical reference threshold. It is intended as a wellness reference rather than a clinical measure.

The model was first described by Matthews et al. in 1985 in Diabetologia (28:412–419) and is widely used in epidemiological and clinical research as a surrogate marker for insulin sensitivity. The gold standard measurement is the euglycemic hyperinsulinemic clamp, which is expensive and impractical outside a research setting. HOMA-IR provides a low-cost research-derived alternative from a routine fasting blood draw. It is not used clinically as a diagnostic test — clinical evaluation requires HbA1c, oral glucose tolerance testing, and assessment by a qualified healthcare provider. HOMA-IR can, however, be a useful self-tracking reference, particularly if you want to monitor trends over time.

Reference Ranges and Their Limitations

The table below shows commonly cited HOMA-IR reference categories. These ranges are derived from published research literature and are widely cited, but they are not universally standardised and are not used to diagnose any condition. No single clinical guideline has formally adopted one cutoff for all populations.

HOMA-IR Score	Commonly Cited Reference
Below 1.0	Within typical range (high insulin sensitivity)
1.0 – 1.9	Upper end of typical range (typical for most healthy adults)
2.0 – 2.9	Above typical range (some studies use 2.5 as a comparison point)
3.0 and above	Significantly above typical range

Important: no universal clinical threshold exists. Reported cutoffs vary considerably by population: approximately 1.6 in some East Asian cohorts, 2.0–2.5 in many European studies, and 2.5–3.0 in American and Latin American populations. Age, sex, ethnicity, body composition, and assay method all influence HOMA-IR values. This tool uses the formula from Matthews et al. 1985 and the reference ranges most commonly cited in Western research literature, presented for general wellness reference only.

Lifestyle Factors Associated with HOMA-IR

Diet. Research links diets high in refined carbohydrates, added sugars, and ultra-processed foods with chronically elevated fasting insulin. Lower-glycaemic, whole-food dietary patterns are associated with improved insulin sensitivity over time.
Physical activity. Both aerobic exercise and resistance training are associated with improved insulin sensitivity in published studies, often within days. Prolonged sedentary behaviour shows the opposite association.
Sleep. Studies show that even one week of restricted sleep (below 6 hours per night) can elevate fasting insulin and HOMA-IR values. Slow-wave sleep in particular has been linked with glucose regulation.
Body composition. Excess visceral fat (abdominal adiposity) is associated with reduced insulin sensitivity in research literature. Modest weight loss of 5–10% of body weight has been associated with meaningful HOMA-IR changes.
Medications. Some medications (corticosteroids, certain antipsychotics, and certain HIV treatments) are associated with reduced insulin sensitivity in research; others (such as metformin, GLP-1 receptor agonists, and SGLT2 inhibitors) are associated with improved insulin sensitivity. Discuss any medications with your healthcare provider when interpreting your result.
Stress hormones. Chronic psychological stress is associated with elevated cortisol, which research links to reduced insulin action and altered fasting glucose and insulin values independently of diet and exercise.

About the Blood Test

Fasting insulin is not included in all standard blood panels but can usually be requested alongside a fasting glucose test. To obtain valid values for the HOMA-IR estimate, both measurements must come from a blood draw taken after a minimum 8-hour overnight fast — typically done in the morning before breakfast. Drinking water is permitted. If you are unsure whether your values were collected fasted, do not use them in this tool, as fed-state insulin levels are substantially higher and would produce a misleading score.

Tracking HOMA-IR as a wellness reference may be of interest to people who already have factors associated with reduced insulin sensitivity in research literature: excess abdominal adiposity, a family history of metabolic conditions, polycystic ovary syndrome (PCOS), elevated triglycerides, low HDL cholesterol, elevated blood pressure, or a history of gestational metabolic changes. Tracking HOMA-IR over time — for example, before and after a dietary or lifestyle change — can provide self-tracking feedback on insulin sensitivity trends. Some related Health3 resources include blood test tracking for type 2 diabetes, blood test tracking for prediabetes, and blood test tracking for insulin resistance monitoring. None of this replaces clinical evaluation — please discuss any concerns with your healthcare provider.

Related Biomarkers and Resources

Frequently Asked Questions

What is HOMA-IR?

HOMA-IR (Homeostasis Model Assessment of Insulin Resistance) is a research-derived mathematical model that estimates insulin sensitivity from fasting glucose and fasting insulin levels. It was first described by Matthews et al. in 1985 (Diabetologia 28:412–419) and is used in research as a surrogate marker for insulin sensitivity. A higher HOMA-IR score is associated with reduced insulin sensitivity. HOMA-IR is not used clinically to diagnose any condition — diagnosis requires HbA1c, oral glucose tolerance testing, and clinical evaluation by a qualified healthcare provider.

How do I interpret my HOMA-IR score?

HOMA-IR is a wellness reference, not a diagnostic measure. Commonly cited reference ranges are: below 1.0 is within typical range for high insulin sensitivity; 1.0–1.9 is upper end of typical range for most adults in Western populations; 2.0–2.9 is above typical range (some references use 2.5 as a comparison point); 3.0 and above is significantly above typical range. There is no single universally accepted cutoff — studies report different thresholds (approximately 1.6 in some East Asian cohorts, 2.0–2.5 in many European studies, up to 3.0 in some American populations) and assay method matters. Always discuss your result with a qualified healthcare provider who knows your full clinical picture.

Does a high HOMA-IR mean I have insulin resistance?

No — a HOMA-IR score on its own cannot tell you whether you have insulin resistance. HOMA-IR is a research-derived estimate from a single fasting blood draw and is not used clinically to diagnose insulin resistance, prediabetes, or type 2 diabetes. Values above the typical range are commonly seen with reduced insulin sensitivity, but a clinical assessment requires HbA1c, oral glucose tolerance testing, fasting glucose patterns over time, and other context that a qualified healthcare provider can evaluate. Use HOMA-IR as a wellness reference and discuss any concerns with your doctor.

Does a high HOMA-IR mean I have prediabetes or type 2 diabetes?

No. HOMA-IR is not used clinically to diagnose prediabetes or type 2 diabetes. Diagnosis of those conditions requires specific tests defined by clinical guidelines — typically fasting plasma glucose, oral glucose tolerance testing, and/or HbA1c, interpreted alongside symptoms and risk factors by a qualified healthcare provider. HOMA-IR can be a useful wellness reference for tracking insulin sensitivity trends over time, but it cannot replace clinical evaluation. If you have concerns about your metabolic health, please speak with your doctor.

Do I need to fast before the blood test?

Yes. Both fasting glucose and fasting insulin must be measured after an overnight fast of 8 to 12 hours. Food raises both glucose and insulin substantially, which would produce an inaccurate (falsely elevated) HOMA-IR score. Water is fine to drink during the fast. The blood draw is typically done in the morning before breakfast. If you are unsure whether your values were collected fasted, do not enter them into this tool.

What lifestyle factors are associated with insulin sensitivity?

Lifestyle factors commonly associated with improved insulin sensitivity in research literature include regular aerobic and resistance exercise, a lower-glycaemic diet rich in whole foods, adequate sleep (7–9 hours per night), maintaining a healthy body composition, and stress management. Some medications can also influence insulin sensitivity. A HOMA-IR score is one of many possible reference points and is not a diagnosis — values in the above-typical range are commonly seen with reduced insulin sensitivity, and any concerns should be discussed with a qualified healthcare provider who can assess your full clinical picture. Repeat testing after lifestyle changes can help track personal trends over time.

Medical Disclaimer: HOMA-IR is a research-derived index of insulin sensitivity calculated from a single fasting blood draw. It is not used clinically to diagnose insulin resistance, prediabetes, type 2 diabetes, or metabolic syndrome. Diagnosis of those conditions requires HbA1c, oral glucose tolerance testing, and clinical evaluation. This tool is for general wellness tracking only and does not replace medical advice. Always consult a qualified healthcare provider. Based on: Matthews DR, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419.

Track Your Insulin & Glucose Over Time

Upload your blood test results to Health3, track HOMA-IR trends as a wellness reference, and see your metabolic markers in one place — with personalised typical ranges alongside lab normals.